FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1449-1450 November 24, 1994 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The intravascular administration of iodinated contrast agents is part of many diagnostic and therapeutic radiologic procedures. Since these agents have no therapeutic value, it is important that they be safe. The contrast agents that have been in use for many years have a high osmolality and are ionic, and their administration has been associated with anaphylactoid events, cardiovascular instability, and nephrotoxicity. Recently, low-osmolality contrast agents, ionic and nonionic, have been introduced to reduce the incidence of side effects.

Nephrotoxicity caused by contrast agents is usually identified clinically by an increase in the serum creatinine concentration. In many studies, the condition . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Mehran, R., Nikolsky, E., Kirtane, A. J., Caixeta, A., Wong, S. C., Teirstein, P. S., Downey, W. E., Batchelor, W. B., Casterella, P. J., Kim, Y.-H., Fahy, M., Dangas, G. D. (2009). Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients: The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study. J Am Coll Cardiol Intv 2: 415-421 [Abstract] [Full Text]  
• Chen, H. H. (2009). Atrial Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy: What's Old Is New But at the Right Dose and Duration of Therapy!. J Am Coll Cardiol 53: 1047-1049 [Full Text]  
• Smyth, A., Garovic, V. D. (2009). 25-Year-Old Man With Flank Pain, Hematuria, and Proteinuria. Mayo Clin Proc. 84: 72-75 [Full Text]  
• Huber, W., Eckel, F., Hennig, M., Rosenbrock, H., Wacker, A., Saur, D., Sennefelder, A., Hennico, R., Schenk, C., Meining, A., Schmelz, R., Fritsch, R., Weiss, W., Hamar, P., Heemann, U., Schmid, R. M. (2006). Prophylaxis of Contrast Material-induced Nephropathy in Patients in Intensive Care: Acetylcysteine, Theophylline, or Both? A Randomized Study.. Radiology 239: 793-804 [Abstract] [Full Text]  
• Yoon, W., Jeong, Y. Y., Shin, S. S., Lim, H. S., Song, S. G., Jang, N. G., Kim, J. K., Kang, H. K. (2006). Acute Massive Gastrointestinal Bleeding: Detection and Localization with Arterial Phase Multi-Detector Row Helical CT. Radiology 239: 160-167 [Abstract] [Full Text]  
• Ergun, I., Keven, K., Uruc, I., Ekmekci, Y., Canbakan, B., Erden, I., Karatan, O. (2006). The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 21: 697-700 [Abstract] [Full Text]  
• Jones, D., Bellomo, R. (2005). Renal-Dose Dopamine: From Hypothesis to Paradigm to Dogma to Myth and, Finally, Superstition?. J Intensive Care Med 20: 199-211 [Abstract]  
• Goldenberg, I., Matetzky, S. (2005). Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172: 1461-1471 [Abstract] [Full Text]  
• Gleeson, T. G., Bulugahapitiya, S. (2004). Contrast-Induced Nephropathy. Am. J. Roentgenol. 183: 1673-1689 [Full Text]  
• Cox, C. D., Tsikouris, J. P. (2004). Preventing Contrast Nephropathy: What Is the Best Strategy? A Review of the Literature. J Clin Pharmacol 44: 327-337 [Abstract] [Full Text]  
• Goldenberg, I., Shechter, M., Matetzky, S., Jonas, M., Adam, M., Pres, H., Elian, D., Agranat, O., Schwammenthal, E., Guetta, V. (2004). Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography: A randomized controlled trial and review of the current literature. Eur Heart J 25: 212-218 [Abstract] [Full Text]  
• Rezkalla, S. H. (2003). Contrast Nephropathy. Clin Med Res 1: 301-304 [Abstract] [Full Text]  
• Huber, W., Ilgmann, K., Page, M., Hennig, M., Schweigart, U., Jeschke, B., Lutilsky, L., Weiss, W., Salmhofer, H., Classen, M. (2002). Effect of Theophylline on Contrast Material-induced Nephropathy in Patients with Chronic Renal Insufficiency: Controlled, Randomized, Double-blinded Study. Radiology 223: 772-779 [Abstract] [Full Text]  
• Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., Perruchoud, A. P., Eriksson, U., Marsch, S., Roskamm, H. (2002). Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty. Arch Intern Med 162: 329-336 [Abstract] [Full Text]  
• Gruberg, L., Mintz, G. S., Mehran, R., Dangas, G., Lansky, A. J., Kent, K. M., Pichard, A. D., Satler, L. F., Leon, M. B. (2000). The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548 [Abstract] [Full Text]  
• Koch, J.-A., Plum, J., Grabensee, B., Modder, U. (2000). Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?. Nephrol Dial Transplant 15: 43-49 [Abstract] [Full Text]